ORAOV1 Inhibitors
Chemical inhibitors of ORAOV1 can play a significant role in modulating its function by targeting the proteolytic processes that are essential for its activity. Benzamidine, known for its capacity to inhibit protease activity, can interfere with the proteolytic cleavage or processing of ORAOV1, which is crucial for its function. Similarly, leupeptin, with its ability to reversibly inhibit serine and cysteine proteases, can disrupt the activation or regulation of ORAOV1 by these enzymes. Pepstatin A, as an aspartyl protease inhibitor, can impede any aspartyl protease-mediated activation that ORAOV1 may require. Additionally, phosphoramidon can inhibit metalloproteases which could be responsible for the processing of ORAOV1, thereby affecting its functionality.
E-64's irreversible inhibition of cysteine proteases can result in the functional blockade of ORAOV1 if its activity hinges on these enzymes. Aprotinin's main target, serine proteases, if involved in the regulation of ORAOV1, can be inhibited, thus affecting ORAOV1's function. Bestatin can impede the maturation or function of ORAOV1 by inhibiting aminopeptidases that might be required by ORAOV1. Furthermore, chymostatin can inhibit serine proteases, which may be necessary for ORAOV1 activity. The proteasome inhibitors, MG-132 and lactacystin, can prevent the degradation of ORAOV1 if it is subjected to such post-translational regulation, leading to an increase in its functional presence. Marimastat can interfere with metalloprotease activity potentially involved in the regulation of ORAOV1, while ALLN's inhibition of both calpain and proteasome pathways indicates a broad-spectrum approach to hindering the degradation or regulation of ORAOV1 function. Through these diverse inhibitory actions, the selected chemicals can exert a comprehensive control over the functional activity of ORAOV1.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Benzamidine | 618-39-3 | sc-233933 | 10 g | $292.00 | 1 | |
Benzamidine is a known protease inhibitor that can inhibit the proteolytic activity of enzymes. If ORAOV1 has protease-like functions or is regulated by protease activity, benzamidine could inhibit ORAOV1 by preventing its proteolytic cleavage or processing. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
Leupeptin is a reversible protease inhibitor that specifically inhibits serine and cysteine proteases. In the event that ORAOV1 is activated or regulated by such proteases, leupeptin's inhibition of these enzymes could result in the functional inhibition of ORAOV1. | ||||||
Phosphoramidon | 119942-99-3 | sc-201283 sc-201283A | 5 mg 25 mg | $199.00 $632.00 | 8 | |
Phosphoramidon inhibits metalloproteases. Should ORAOV1 be processed or regulated by metalloprotease activity, phosphoramidon could inhibit this processing, thereby inhibiting ORAOV1 function. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E-64 irreversibly inhibits cysteine proteases. If ORAOV1 requires cysteine protease activity for its function or activation, inhibition by E-64 would result in the functional inhibition of ORAOV1. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
Aprotinin is a protease inhibitor that mainly inhibits serine proteases. If ORAOV1's function is dependent on the activity of serine proteases, aprotinin's inhibition of these enzymes could inhibit ORAOV1. | ||||||
Bestatin | 58970-76-6 | sc-202975 | 10 mg | $131.00 | 19 | |
Bestatin inhibits aminopeptidases. If ORAOV1 requires aminopeptidase activity for its maturation or function, inhibition of aminopeptidases by bestatin could lead to the functional inhibition of ORAOV1. | ||||||
Chymostatin | 9076-44-2 | sc-202541 sc-202541A sc-202541B sc-202541C sc-202541D | 5 mg 10 mg 25 mg 50 mg 100 mg | $156.00 $260.00 $640.00 $1186.00 $2270.00 | 3 | |
Chymostatin is a chymotrypsin inhibitor that can inhibit serine proteases. If serine protease activity is necessary for ORAOV1 function, inhibition by chymostatin could lead to the functional inhibition of ORAOV1. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is a proteasome inhibitor that can inhibit the degradation of proteins. If ORAOV1 is regulated through proteasomal degradation, MG-132 could inhibit this process, leading to the functional inhibition of ORAOV1. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Lactacystin is a specific inhibitor of the proteasome. If ORAOV1 degradation is mediated by the proteasome, lactacystin's inhibition of this pathway could inhibit the functional activity of ORAOV1. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
Marimastat is a broad-spectrum metalloprotease inhibitor. If ORAOV1 activity is regulated by metalloprotease activity, marimastat could inhibit those enzymes, thereby inhibiting ORAOV1 function. | ||||||